Delivery Order SPE2DB22D3501-SPE2DB25FVH73
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,101.53, is for the supply of the pharmaceutical product Briviact 100 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 17, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,671.40 firm fixed-price contract is for the delivery of the drug Briviact in 100 mg tablet form, with a period of performance through April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Briviact 100 mg tablet in 60-count packages. The contract has a firm fixed price of $5,815.50 and a completion date of September 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December...
This federal contract award, valued at $3,248.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,968,400 units of the prescription medication Briviact 75 mg tablet. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp. The $1,702.34 contract is for the delivery of 60-count tablets of the pharmaceutical product Briviact 50 mg. The contract has a firm fixed price pricing type and an ultimate completion date of June 3, 2024. This appears to be a single-award, rather than a set-aside, contract. Amerisourcebergen Drug Corp, a major...
This is a $5,963.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60-count bottles of the prescription drug Briviact 100 mg tablets. The delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact 50 mg tablets. The $11,768.64 contract has an ultimate completion date of April 12, 2023 and is a firm fixed-price delivery order, with no set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the brand-name drug Briviact 75 mg tablets. The contract has a ceiling value of $2,875.05 and a period of performance through December 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,678.29, is for the delivery of the drug Briviact 50 mg tablets. The contract is a firm fixed price delivery order with a completion date of January 21, 2025. There is no set-aside designation for this contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,252.41, is for the supply of 60 tablets of the pharmaceutical drug Briviact 50 mg. The contract is a firm fixed price arrangement and does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this order is part...